Last filing: Oct 5, 2026. Most recent purchase on record: Feb 3, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| PNC Financial Services (PNC) | Director | Feb 5, 2025 | Oct 5, 2026 |
| BridgeBio Pharma, Inc. (BBIO) | Director | Aug 26, 2021 | Jun 24, 2026 |
| American International Group (AIG) | Former EVP and CIO | Oct 2, 2015 | Jul 1, 2021 |
Also a director at
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 22, 2026, BridgeBio Pharma, Inc.: 3,990 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.